Literature DB >> 24006141

Acute HIV-1 seroconversion with an unusual plasma biomarker profile.

Najib Aziz1, Roger Detels, Otoniel Martinez-Maza, John Oishi, Beth D Jamieson, Mallory D Witt, Anthony W Butch.   

Abstract

An unusual case of acute primary HIV-1 infection in a man with a high plasma viral load, a 51-fold increase in C-reactive protein, and antibodies against only gp160 is described. Numerous serum cytokine concentrations were elevated during HIV-1 seroconversion.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24006141      PMCID： PMC3837784          DOI： 10.1128/CVI.00366-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  21 in total

1.  Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.

Authors:  Pratip K Chattopadhyay; Daniel C Douek; Stephen J Gange; Karen R Chadwick; Marc Hellerstein; Joseph B Margolick
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

2.  IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction.

Authors:  Dorothée Missé; Hans Yssel; Daria Trabattoni; Christelle Oblet; Sergio Lo Caputo; Francesco Mazzotta; Jérome Pène; Jean-Paul Gonzalez; Mario Clerici; Francisco Veas
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Clinical and epidemiologic features of primary HIV infection.

Authors:  T Schacker; A C Collier; J Hughes; T Shea; L Corey
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

4.  Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.

Authors:  Z Liu; W G Cumberland; L E Hultin; H E Prince; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-10-01

5.  Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.

Authors:  N Aziz; P Nishanian; J M Taylor; R T Mitsuyasu; J M Jacobson; B J Dezube; M M Lederman; R Detels; J L Fahey
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

6.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Cytokine network and acute primary HIV-1 infection.

Authors:  A Sinicco; A Biglino; M Sciandra; B Forno; A M Pollono; R Raiteri; P Gioannini
Journal:  AIDS       Date:  1993-09       Impact factor: 4.177

8.  Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.

Authors:  J L Fahey; J M Taylor; B Manna; P Nishanian; N Aziz; J V Giorgi; R Detels
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

9.  Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.

Authors:  C R Rinaldo; L A Beltz; X L Huang; P Gupta; Z Fan; D J Torpey
Journal:  AIDS Res Hum Retroviruses       Date:  1995-04       Impact factor: 2.205

10.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.